Global Edition
Global Edition
UK Edition
EU Edition
US Edition

Understand the story, not the spin.

Markets

Missouri judge approves Bayer’s $7.25 billion Roundup settlement

Published 21 November 2026 · All stories from this day

A Missouri judge has approved Bayer’s settlement of U.S. lawsuits alleging that its Roundup weed killer caused cancer, clearing the way for payments of up to $7.25 billion over as many as 21 years. Bayer denies that Roundup causes cancer, and the settlement does not resolve the scientific dispute over glyphosate, the herbicide’s active ingredient.

The agreement covers people diagnosed with non-Hodgkin lymphoma after exposure to Roundup before the settlement was proposed in February, including people who receive diagnoses in future years. Average payments are expected to range from $10,000 to $165,000, depending on exposure, age at diagnosis and illness severity.

Bayer will make annual payments into a fund for up to 21 years. The amount an individual receives will depend on the settlement’s criteria. The court’s approval order also includes $600 million for attorneys’ fees, according to the order described in the case reporting.

The judge, St. Louis Circuit Judge Timothy Boyer, found the average individual payouts fair and adequate. Some attorneys representing plaintiffs support the deal because it guarantees compensation amid legal uncertainty; others say the payments are too low...

Now playing
0:00 / 0:00